$31.57
0.080.25%
Last update: Nov 13, 9:01 AM
IDEAYA Biosciences Inc
IDYANASDAQ
IDEAYA Biosciences fell 1.0% from $31.82 to $31.49, behind the S&P 500's +12.7%. Its worst day was Jun 9 (−10.8%), and its low came Jun 10 at $27.60.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.94 beat the $-0.98 estimate on $10.9M revenue (est. $9.2M).
+1.6% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
IDEAYA Biosciences shares rose 7.6%, while the S&P 500 rose 1.0%.
+7.6%, on 10M shares, the year's heaviest volume · S&P 500 +1.0%
EPS of $-1.11 missed the $-1.00 estimate on $6.6M revenue (est. $6.1M).
−0.3% · S&P 500 +0.8%
IDEAYA Biosciences closed at its lowest level of the year, 13.3% below where the year started.
−1.7% · S&P 500 −1.6%
IDEAYA Biosciences shares rose 9.6%, while the S&P 500 fell 0.3%.
+9.6% · S&P 500 −0.3%
EPS of $-1.22 missed the $-1.08 estimate on $8.9M revenue (est. $7.4M).
+2.0% · S&P 500 +1.8%
IDEAYA Biosciences closed at its highest level of the year, 33.5% above where the year started.
+6.1% · S&P 500 +0.3%
EPS of $-1.22 missed the $-1.18 estimate on $10.2M revenue (est. $7.9M).
−1.0% · S&P 500 +0.3%
Where it ended: a close of $31.49 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 16, 2027 (EPS est. $-1.17, revenue est. $18.8M).
Nothing in the past 12 months.
All IDYA dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IDYA and SPY from Benzinga historical bars. Not investment advice.
